Eli Lilly 2005 Annual Report Download - page 87

Download and view the complete annual report

Please find page 87 of the 2005 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 100

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100

PROX Y S TATEM ENT
8585
Principal Holders of Stock
To the best of the company’s knowledge, the only beneficial owners of more than 5 percent of the outstanding
shares of the company’s common stock are Lilly Endowment, Inc. (the “Endowment”), Capital Research and
Management Company, and Wellington Management Company, LLP. The following table sets forth information
regarding this ownership:
Number of Shares Percent of
Name and Address Beneficially Owned Class
Lilly Endowment, Inc. 147,645,804 13.0%
2801 North Meridian Street (as of February 1, 2006)
Indianapolis, Indiana 46208
Capital Research and Management Company 80,429,400 7.1%
333 South Hope Street (as of December 31, 2005)
Los Angeles, California 90071
Wellington Management Company, LLP 66,995,567 5.9%
75 State Street (as of December 30, 2005)
Boston, Massachusetts 02109
The Endowment has sole voting and sole investment power with respect to its shares. The board of directors of the
Endowment is composed of Mr. Thomas M. Lofton, chairman; Mr. N. Clay Robbins, president; Mrs. Mary K. Lisher;
Drs. Otis R. Bowen and William G. Enright; and Messrs. Daniel P. Carmichael, Eli Lilly II, and Eugene F. Ratliff
(Emeritus Director). Each of the directors is, either directly or indirectly, a shareholder of the company.
Capital Research and Management Company acts as investment adviser to various registered investment
companies. It has sole voting power with respect to 13,489,100 shares (approximately 1.2 percent of shares out-
standing) and sole investment power with respect to all of its shares.
Wellington Management Company, LLP acts as investment adviser to various clients. It has shared voting
power with respect to 27,970,771 shares (approximately 2.5 percent of shares outstanding) and shared investment
power with respect to all of its shares.